Insider Transactions in Q3 2021 at Pliant Therapeutics, Inc. (PLRX)
Insider Transaction List (Q3 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 03
2021
|
Keith Lamont Cummings Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
20,000
+22.83%
|
$40,000
$2.08 P/Share
|